[Press release] ViiV Healthcare | Five years of US real-world evidence reinforce the durable effectiveness and long-term persistence of Cabenuva
ViiV Healthcare reports that five years of US real-world evidence confirms the long-term effectiveness and persistence of Cabenuva, a long-acting HIV treatment.
The story
in brief.
What happened, who it affects, and why it landed on our intelligence desk — in plain English, sixty seconds or less.
ViiV Healthcare reports that five years of US real-world evidence confirms the long-term effectiveness and persistence of Cabenuva, a long-acting HIV treatment. The data, presented at the European AIDS Treatment Group conference, highlights the drug’s sustained viral suppression rates and patient retention. This milestone underscores the clinical value of injectable therapies over daily oral regimens. For professionals in pharma and healthcare, this reinforces the growing importance of real-world evidence in validating treatment outcomes and supporting regulatory and commercial strategies for novel delivery mechanisms.
Indicative index of skill mentions in professional job postings for the field this story moves (2019 = 1)
What this means
for your career.
Every headline redistributes opportunity. Here is who this one rewards — and how to be on the right side of it.
This development signals a shift toward value-based healthcare, where long-term patient outcomes drive commercial success. Professionals in pharma and healthcare management must prioritise skills in real-world evidence generation and health economics. If you work in these sectors, focus on understanding how durable efficacy impacts reimbursement and market access. Smart professionals will upskill in data analytics to interpret longitudinal patient data, enabling better strategic decisions. Those in commercial roles should explore training in Healthcare Management to navigate the evolving landscape of long-acting therapies. Mastering these areas will position you to lead initiatives that align clinical evidence with business strategy, ensuring your organisation stays competitive in a market increasingly driven by proven, sustained patient benefits.
For this story, the fields that convert it into pay are Healthcare Management, Data analytics, Business analysis and Health and Social Care — exactly the programmes matched below. The chart shows the indicative salary uplift certified professionals report in each of those fields; every one of them is a click away, from £79, finishing in as few as 20 days.
Indicative ranges from published continuing-education salary studies, by field — each field is a recommended course below
Enrol in these
to benefit.
These programmes position you for exactly this shift — online, self-paced, and finishing with a verifiable certificate you can share the day you pass.
Best match
Certificate in Healthcare Management
Recommended
Certificate in Data analytics
Recommended
Certificate in Business analysis
Recommended
Certificate in Health and Social Care
Launch pricing shown against standard certificate value. The fee you see today is the fee you lock in.
This briefing is based on reporting by European AIDS Treatment Group on 21 Oct, 23:14. Read the original coverage →
Read the news. Then outrun it.
Every LSBR programme is online, self-paced and from £79 — so a headline today can be your credential this month.